Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,529.00
-25.2 (-0.99%)
BSENSE

Dec 19

BSE+NSE Vol: 1.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.99%
0.58%
1W
-2.76%
-0.31%
1M
0.4%
-0.33%
YTD
12.31%
9.82%
1Y
8.71%
8.41%
3Y
89.62%
40.97%
5Y
56.85%
88.7%
10Y
54.43%
234.53%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.74%
0%
-7.74%
6 Months
-20.95%
0%
-20.95%
1 Year
8.71%
0%
8.71%
2 Years
44.96%
2.25%
47.21%
3 Years
89.62%
5.84%
95.46%
4 Years
41.31%
7.72%
49.03%
5 Years
56.85%
10.93%
67.78%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-4.91%
4
Quartile
quartile-4
Jun-Sep
-21.5%
1
Quartile
quartile-1
Mar-Jun
17.63%
2
Quartile
quartile-2
YTD
8.71%
3
Quartile
quartile-3
2024
18.63%
2
Quartile
quartile-2
2023
43.94%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.91%
4
Quartile
quartile-4
Jun-Sep
-21.5%
2
Quartile
quartile-2
Mar-Jun
17.63%
1
Quartile
quartile-1
YTD
8.71%
3
Quartile
quartile-3
2024
18.63%
2
Quartile
quartile-2
2023
43.94%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-4.91%
4
Quartile
quartile-4
Jun-Sep
-21.5%
2
Quartile
quartile-2
Mar-Jun
17.63%
2
Quartile
quartile-2
YTD
8.71%
3
Quartile
quartile-3
2024
18.63%
3
Quartile
quartile-3
2023
43.94%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available